Condition
Bacterial Vaginosis | Vaginal | Microbiology
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05590195Phase 3Unknown
Effect of PreforPro® on Urinary and Vaginal Health
NCT04489290Not ApplicableUnknownPrimary
Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis
NCT05669963Phase 2UnknownPrimary
Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy
Showing all 3 trials